Literature DB >> 27131005

Carriage prevalence of Salmonella enterica serotype Typhi in gallbladders of adult autopsy cases from Mozambique.

Lucilia Lovane1, Miguel J Martinez, Sergio Massora, Inacio Mandomando, Esperança Ussene, Dercio Jordao, Paola Castillo, Mamudo R Ismail, Cesaltina Lorenzoni, Carla Carrilho, Quique Bassat, Clara Menendez, Jaume Ordi, Jordi Vila, Sara Maria Soto.   

Abstract

INTRODUCTION: Typhoid fever is an important public health problem in many low-income countries where asymptomatic carriers play an important role in its dissemination. The bacterium causing typhoid fever can live in the gallstones of asymptomatic persons after the infection. These carriers are reservoirs of S. Typhi, are highly contagious, and spread the disease through the secretion of bacteria in feces and urine. The aim of this study was to determine the carrier rate in an area of Mozambique.
METHODOLOGY: The presence of S. Typhi was analyzed in gallbladder samples obtained from 99 adult corpses (in-hospital deaths) from Mozambique by gold-standard culture and polymerase chain reaction (PCR).
RESULTS: Only one sample was positive with the culture. However, nine additional samples were positive by PCR and confirmed by DNA sequencing. Thus, the prevalence of S. Typhi was 10.1% (10/99).
CONCLUSIONS: We report a high prevalence of S. Typhi in gallbladders among adult autopsy cases from Mozambique.

Entities:  

Mesh:

Year:  2016        PMID: 27131005     DOI: 10.3855/jidc.7306

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  2 in total

Review 1.  Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.

Authors:  Yi-An Yang; Alexander Chong; Jeongmin Song
Journal:  Vaccines (Basel)       Date:  2018-07-24

Review 2.  Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella.

Authors:  Amber J Barton; Jennifer Hill; Christoph J Blohmke; Andrew J Pollard
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.